HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary precursor B cell lymphoblastic lymphoma of uterine corpus: case report and review of the literature.

AbstractINTRODUCTION:
Primary lymphomas of the female genital tract are rare. Most involve the cervix rather than the uterine corpus. Many cases of primary endometrial lymphoma are diagnosed as diffuse large B cell type, whereas the precursor B cell lymphoblastic type is extremely rare.
MATERIALS AND METHODS:
We report a case of precursor B cell lymphoblastic lymphoma of uterine corpus which was successfully treated with surgery and chemotherapy. Staging evaluation revealed tumor limited to the uterine corpus (stage I(E)). After receiving a total abdominal hysterectomy, bilateral salpingooophorectomy, lymph node dissection and combination chemotherapy, the patient is currently free of disease after follow-up of 42 months.
CONCLUSION:
If correct diagnosis is established and appropriate therapy is chosen, the prognosis of precursor B-LBL of uterine corpus is expected to be good. The literature on primary precursor B cell lymphoblastic lymphoma of the uterine corpus is reviewed.
AuthorsShi-Sheng Tan, Xing-Chen Peng, Ying Cao
JournalArchives of gynecology and obstetrics (Arch Gynecol Obstet) Vol. 284 Issue 5 Pg. 1289-92 (Nov 2011) ISSN: 1432-0711 [Electronic] Germany
PMID21193918 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antineoplastic Agents
Topics
  • Adult
  • Antineoplastic Agents (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols
  • Combined Modality Therapy
  • Female
  • Humans
  • Hysterectomy (methods)
  • Lymph Node Excision
  • Ovariectomy (methods)
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (drug therapy, pathology, surgery, therapy)
  • Uterine Neoplasms (drug therapy, pathology, surgery, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: